MedTrace Logo

Immune Status in Solid Organ Transplantation

NCT01070901 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-02-05

No results posted yet for this study

Summary

Immunosuppressive therapy protocols in solid organ transplantation are rudimentary, differ by transplant center and no practical strategies are available to guide an individuals' response to immune suppression. In this study we will conduct research to assess immunologic status in solid organ transplant recipients, predicting immune reconstitution and outcomes after transplant to better guide the use of immunosuppressive medications.

Conditions

  • Organ Transplants

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01070901 on ClinicalTrials.gov